• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Vanda Pharmaceuticals

The Vanda Nereus-branded No 47 IndyCar
Marketing

Vanda shifts into high gear with Schumacher IndyCar sponsorship

The biotech backed the No. 47 car to represent its ending of the multi-decade wait for a prescription therapy.
Nick Paul Taylor Jul 16, 2026 1:13pm
motion sickness

Vanda tests motion sickness drug Nereus in GLP-1 patients

Apr 9, 2026 2:56pm
FDA

Vanda secures long-awaited FDA hearing in jet lag approval bid

Mar 4, 2026 3:22pm
green light go go ahead advance yes streetlight

FDA signs off on Vanda's Bysanti for schizophrenia and bipolar I

Feb 23, 2026 11:35am
jet lag sleep disorder

FDA rejects Vanda's Hetlioz for a 2nd time in jet lag disorder

Jan 8, 2026 11:20am
two green lights

Vanda, Agios score holiday season FDA approvals

Jan 2, 2026 11:33am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings